Invention Grant
- Patent Title: Regulatory elements
- Patent Title (中): 监管要素
-
Application No.: US13773845Application Date: 2013-02-22
-
Publication No.: US08975391B2Publication Date: 2015-03-10
- Inventor: Barbara Enenkel
- Applicant: Barbara Enenkel
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
- Current Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edouard G. Lebel
- Priority: EP08161029 20080723
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12P1/00 ; C12P21/06 ; C12P21/04 ; C12N5/07 ; C12N15/67 ; C12N15/63

Abstract:
The invention concerns novel regulatory elements as well as related vectors and cells. Furthermore, it relates to methods of improving expression of polypeptides from nucleic acids such as cloned genes and to the production of various polypeptides in host cells using said novel regulatory elements. Additionally, the invention relates to uses of said novel regulatory elements as insulators, in gene therapy or for improving host cell lines.
Public/Granted literature
- US20130177943A1 NOVEL REGULATORY ELEMENTS Public/Granted day:2013-07-11
Information query